Literature DB >> 21338262

Determination of oseltamivir (Tamiflu®) and oseltamivir carboxylate in dried blood spots using offline or online extraction.

Katja Heinig1, Thomas Wirz, Franz Bucheli, Almudena Gajate-Perez.   

Abstract

BACKGROUND: Using dried blood spots (DBS) for quantitation of the antiviral drug oseltamivir (Tamiflu(®)), an ester prodrug, and its active metabolite oseltamivir carboxylate could provide ethical and logistic benefits. Hence, its feasibility was investigated using a previously developed column-switching LC-MS/MS method.
RESULTS: Sensitivity, precision and accuracy in DBS were comparable to standard plasma assays. Chemically treated cards provided enhanced ex vivo stability of the ester prodrug in rodent blood. Online extraction was realized using the manual TLC-MS interface or the fully automated Sample Card and Prep system. Rat pharmacokinetic study data showed good correlation between plasma, liquid blood and DBS.
CONCLUSION: From a bioanalytical perspective, DBS is potentially suited for Tamiflu analysis in animals and humans. Automation of the process by online DBS extraction promises workload reduction and throughput increase.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21338262     DOI: 10.4155/bio.11.4

Source DB:  PubMed          Journal:  Bioanalysis        ISSN: 1757-6180            Impact factor:   2.681


  5 in total

1.  Validation of a ligand binding assay using dried blood spot sampling.

Authors:  Daniel Burns; Laura Brunner; Surendran Rajendran; Beth Johnson; Mark Ma; Jin Wang
Journal:  AAPS J       Date:  2012-11-08       Impact factor: 4.009

2.  Comparison of the quantification of acetaminophen in plasma, cerebrospinal fluid and dried blood spots using high-performance liquid chromatography-tandem mass spectrometry.

Authors:  Rachel R Taylor; Keith L Hoffman; Björn Schniedewind; Claudia Clavijo; Jeffrey L Galinkin; Uwe Christians
Journal:  J Pharm Biomed Anal       Date:  2013-04-16       Impact factor: 3.935

3.  Simple and sensitive assay for quantification of oseltamivir and its active metabolite oseltamivir carboxylate in human plasma using high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry: improved applicability to pharmacokinetic study.

Authors:  Zhe-Yi Hu; S Casey Laizure; Bernd Meibohm; Vanessa L Herring; Robert B Parker
Journal:  J Pharm Biomed Anal       Date:  2012-09-05       Impact factor: 3.935

4.  Dried blood spot UHPLC-MS/MS analysis of oseltamivir and oseltamivircarboxylate--a validated assay for the clinic.

Authors:  Gero P Hooff; Roland J W Meesters; Jeroen J A van Kampen; Nick A van Huizen; Birgit Koch; Asmar F Y Al Hadithy; Teun van Gelder; Albert D M E Osterhaus; Rob A Gruters; Theo M Luider
Journal:  Anal Bioanal Chem       Date:  2011-05-03       Impact factor: 4.142

5.  Simultaneous quantification of prodrug oseltamivir and its metabolite oseltamivir carboxylate in human plasma by LC-MS/MS to support a bioequivalence study.

Authors:  Ajay Gupta; Swati Guttikar; Pranav S Shrivastav; Mallika Sanyal
Journal:  J Pharm Anal       Date:  2012-12-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.